Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00486330 · ClinicalTrials.gov registry record · NA

Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir

A NA study of HIV Infections, sponsored by Yale University.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT00486330 is a NA study of HIV Infections that has completed, run by Yale University. The registered enrollment target is 12 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00486330, a NA study of HIV Infections, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study is to examine the effect of tipranavir combined with ritonavir, medications for the treatment of HIV-infection, on buprenorphine/naloxone (BUP) in people who have been receiving the same dose of buprenorphine/naloxone for at least 3 weeks before study entry.

Conditions Studied

HIV Infections

Interventions

  • DRUG Buprenorphine, Tipranavir and ritonavir

Study Locations (1)

Connecticut

  • Yale University School of Medicine AIDS Program - New Haven

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2006-05
Est. Completion 2007-05
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00486330

The ClinicalTrials.gov registry entry for NCT00486330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (97% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Buprenorphine, Tipranavir and ritonavir is the first listed.

NCT00486330 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00486330 about?

NCT00486330 is a clinical study titled "Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir". The main purpose of this study is to examine the effect of tipranavir combined with ritonavir, medications for the treatment of HIV-infection, on buprenorphine/naloxone (BUP) in people who have been receiving the same dose of buprenorphine/naloxone for at least 3 weeks before study entry.

What is the current status of trial NCT00486330?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2006-05. Estimated completion is 2007-05.

What conditions does trial NCT00486330 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00486330?

The interventions under investigation include: Buprenorphine, Tipranavir and ritonavir (DRUG).

Who is sponsoring clinical trial NCT00486330?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00486330 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.